The proportional decrease in risk between an experimental intervention and a control intervention constitutes a crucial metric in assessing the efficacy of that experimental intervention. It is determined by first calculating the absolute risk reduction (ARR), which is the difference in event rates between the two groups. Then, the ARR is divided by the event rate in the control group. The resulting ratio represents the proportion of the baseline risk that is removed by the intervention. For example, if a control group has a 10% risk of developing a disease and an intervention group has a 5% risk, the absolute risk reduction is 5%. Dividing this by the control group risk (10%) yields a value of 0.5, or 50%. This indicates a 50% proportional reduction in risk.
This metric is valuable for clinicians and policymakers as it quantifies the proportional impact of an intervention, allowing for a clear understanding of its potential benefit. Understanding this proportional reduction assists in evaluating the effectiveness of preventative measures or therapeutic treatments. While the absolute risk reduction indicates the net reduction in risk, the proportional reduction provides context by relating the reduction to the initial risk level. This relative perspective provides important context for decision-making, especially when considering the costs, burdens, and potential harms associated with implementing the intervention. Understanding this can also assist in informing patients about the potential magnitude of benefit from a treatment.
